Renal denervation for arrhythmias: Hope or hype?

Current Cardiology Reports

Volumn 15, Issue 9, 2013, Pages

  Steinberg, Jonathan S ^a,c   Pokushalov, Evgeny ^b   Mittal, Suneet ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^c NONE   (United States)

Author keywords

Antiarrhythmia; Arrhythmias; Atrial fibrillation; Renal artery denervation; Ventricular tachycardia

Indexed keywords

ABLATION THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; EFFERENT NERVE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; NONHUMAN; RENAL ARTERY; SENSORY NERVE; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; TREATMENT RESPONSE; ANIMAL; ARRHYTHMIAS, CARDIAC; COMPLICATION; DISEASE MODEL; INNERVATION; KIDNEY; PROCEDURES; SYMPATHECTOMY; METHODOLOGY; REVIEW;

ANIMALS; ARRHYTHMIAS, CARDIAC; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; RENAL ARTERY; SYMPATHECTOMY;

EID: 84885094757     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0392-0     Document Type: Article

References (29)

1. Stella A, Zanchetti A. Functional role of renal afferents. Physiol Rev. 1991;71:659-82.
2. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197. (Pubitemid 27069290)
3. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 1997;51:722-7. (Pubitemid 27157956)
4. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs; electrophysiological remodeling. Circulation. 1996;94:2953-60. (Pubitemid 26411765)
5. Kumagai K, Nakashima H, Urata H, et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol. 2003;41:2197-204. (Pubitemid 36724267)
6. Nakashima H, Kumagai K, Urata H, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000;101:2612-7. (Pubitemid 30350640)
7. Berkowitsch A, Neumann T, Kuniss M, et al. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder? PACE. 2010;33:1101-11.
8. Healy JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832-9. (Pubitemid 40789940)
9. GISSI-AF Investigators. Valsartan for prevention of recurrent atrial fibrillation. N Eng J Med. 2009;360:1606-17.
10. Schlaich MP, Kaye DM, Lambert E, et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560-5. (Pubitemid 36961170)
11. Burns J, Sivananthan MU, Ball SG, et al. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation. 2007;115:1999-2005. (Pubitemid 46625950)
12. Kaye DM, Lambert GW, Lefkovits J, et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-8. (Pubitemid 24074931)
13. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-63.
14. Yang SS, Han W, Cao Y, et al. Effects of high thoracic epidural anesthesia on atrial electrophysiological characteristics and sympathetic nerve sprouting in a canine model of atrial fibrillation. Basic Res Cardiol. 2011;106:495-506.
15. Tan AY, Zhou S, Ogawa M, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation. 2008;118:916-25.
16. Sobotka PA, Mahfoud F, Schlaich MP, et al. Sympatho-renal axis in chronic disease. Clin Res Cardiol. 2011;100:1049-57.
17. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Eng J Med. 2009;361:932-4.
18. Patterson E, Po SS, Scherlag BJ, Lazzara R. Triggered firing of pulmonary veins by in vitro autonomic nerve stimulation. Hear Rhythm. 2005;2:624-31. (Pubitemid 40724130)
19. Lau DH, Mackenzie L, Kelly DJ, et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Hear Rhythm. 2010;7:1282-90.
20. Linz D, Mahfoud F, Schotten U, et al. Renal sympathetic denervation provide ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension. 2013;61:225-31.
21. Zhao Q, Yu S, Zou M, et al. Effects of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. JICE. 2012;35:119-25.
22. Linz D, Mahfoud F, Schotten U, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60:172-8.
23. Kline RL, Mercer PF. Functional reinnervation and development of supersensitivity to NE after renal denervation in rats. Am J Physiol. 1980;238:R353-8. (Pubitemid 10062890)
24. Arrowood JA, Goureau JA, Minisi AJ, Davis AB, Mohanty PK. Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation. Circulation. 1995;92:402-8.
25. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009;54:690-7.
26. •• Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-70. This is the first study, performed as a prospective randomized trial, to demonstrate proof of principle that RDN may have clinical antiarrhythmic efficacy for AF.
27. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof of principle study. Lancet. 2009;373:1275-81.
28. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20:933-9.
29. • Ukena C, Bauer A, Mahfoud F, et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2012;101:63-7. This is the first report of the potential value of RDN to treat refractory VT in patients.